Related Experiment Video
Updated: Jan 6, 2026
Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
Simvastatin impairs fracture healing under ischemic conditions
S Schreiber1, J Stutz1, J Finkler1
1Department of Trauma, Hand and Reconstructive Surgery, Saarland University, Homburg, Germany.
Simvastatin impairs fracture healing in ischemic conditions, reducing bone formation and altering angiogenesis and osteogenesis markers. Clinical use during fracture healing requires careful reconsideration.
Area of Science:
- Orthopedics
- Pharmacology
- Biomedical Engineering
Background:
- Fracture patients often require simvastatin due to comorbidities.
- The effect of simvastatin on fracture healing under ischemia is not well understood.
Purpose of the Study:
- To investigate the impact of simvastatin on fracture healing in a murine model of limb ischemia.
Main Methods:
- Murine model with femoral fracture and hind limb ischemia.
- Simvastatin or vehicle treatment post-fracture stabilization.
- Analysis via biomechanical, radiological, histomorphometric, and Western blot methods at 2 and 5 weeks.
Main Results:
- Simvastatin treatment significantly reduced bone formation in callus tissue.
- Histomorphometry showed delayed healing and less bone tissue in simvastatin-treated femurs.
- Increased CD31 and PI3K expression, decreased BMP-2 expression observed with simvastatin.
Conclusions:
- Simvastatin impairs fracture healing under ischemic conditions.
- Likely mechanism involves an imbalance between angiogenesis and osteogenesis.
- Clinical use of simvastatin during ischemic fracture healing warrants caution.
More Related Videos
07:35Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
Published on: April 11, 2012
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
